ESTIMATEDDate confidence: ESTIMATEDA target, not a fixed dateHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all ESTIMATED pins70% CONFIDENCEOverall confidence: 70%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins from 50% to 74% confidence
The Global Fund[1][3] writes "Generic lenacapavir is expected to enter the market by the end of 2026", giving no day, so the pin takes 31 December.The Global Fund expects generic lenacapavir, the twice-yearly HIV prevention injection, to enter the market by the end of 2026, with 24 countries worldwide due to receive it by then. Nearly 100,000 people in nine high-burden African countries had received it by mid-August 2026.
1.00